Genelux Investor Presentation Deck
October 2023, 38 slides
  1. Genelux
  2. Related Decks
  3. Investor Presentation Decks
redefining oncology | Genelux
forward looking statements | Genelux
highlights | Genelux
the most advanced non local delivery | Genelux
diversified designs and indications exploit competitive advantages bene | Genelux
selective replication in tumors unleashes immune system against cancer | Genelux
primed overcoming drug resistance | Genelux
over billion in transactions in active space a eer | Genelux
competitive advantages of as an virus broad spectrum activity vee nonhuman pathogen | Genelux
creating a new paradigm of virus drug development here and now our advantage | Genelux
phase anti tumor activity as leading into combination regimen prior prior | Genelux
completed phase tested primed in heavily patients with platinum resistant or platinum refractory ovarian cancer published in jama oncology link | Genelux
clinically meaningful responses in heavily patients rescore a | Genelux
demonstrated deep and durable tumor shrinkage | Genelux
primed overcomes refractoriness | Genelux
durable benefit of overall survival via clinically validated | Genelux
approach may reset life clock of heavily treated patients | Genelux
phase pivotal trial design founded on phase trial design results | Genelux
systemic administration demonstrated dose dependent benefit | Genelux
systemic administration generated encouraging data institute expanded access program | Genelux
has partnered with top | Genelux
validating industry collaboration with as mid from clinical trials of in china | Genelux
act therapeutics joint venture between and | Genelux
estimated billion dollar plus annual commercial opportunity us ovarian cancer market market non small cell lung in | Genelux
integrated and manufacturing capabilities for phase and launch large scale process to optimize production | Genelux
commercial strategy | Genelux
choice platform library vectors with | Genelux
intellectual property market exclusivity freedom to operate strong regulatory designations a | Genelux
accomplished leadership team operations | Genelux
has executed on multiple milestones and is positioned for the future a a | Genelux
expected operating runway into shares outstanding cash equivalents insider ownership | Genelux
highlights | Genelux
redefining oncology | Genelux
accomplished clinical advisory board | Genelux
demonstrates and immune activation patient samples a | Genelux
cells infiltrating lymphocytes are prognostic for response survival | Genelux
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
ideal backbone for combination therapy converts tumor to inflammatory hot spot bene | Genelux
See More
Genelux
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Tumor
Ovarian
Lung
Ovarian cancer
Clinical trial
Cell therapy
Recent decks by Genelux
Investor Presentation
February 2024
Investor Presentation
December 2023
Investor Presentation
July 2023
See all presentations by Genelux (4 decks)
Related decks
TCR2 Therapeutics
Results
September 2022
Immatics
Investor Presentation
November 2023
Allarity Therapeutics
Investor Conference
September 2022
BioNTech
Results
May 2021
BioNTech
Results
November 2021
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
March 2024
Mink Therapeutics
IPO
October 2021
Recent decks by Genelux
See all presentations (4 decks)
Investor Presentation
February 2024
Investor Presentation
December 2023
Investor Presentation
July 2023
TCR2 Therapeutics
Results
September 2022
Immatics
Investor Presentation
November 2023
Allarity Therapeutics
Investor Conference
September 2022
BioNTech
Results
May 2021
BioNTech
Results
November 2021
Immix Biopharma
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
March 2024
Mink Therapeutics
IPO
October 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io